ACCP Virtual Journal Club April 2026 – Assessment of Hepatic Impairment and Implications for Pharmacokinetics of Substance Use Treatment – Live
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
AMA PRA Category 1 Credit™Up to 1 credit
MOC types
No MOC
FDA REMS
No
Qualifies for MIPS
No
Start Date
April 22, 2026
End Date
April 23, 2027
Target Specialties
Address:
- P.O. Box 1758
Top 6 courses
-
2026 Digital Health Webinar1.5 Credits
-
-
-
-
-
Specialties served/covered
- Addiction Medicine
- Advanced Heart Failure & Transplant Cardiology
- Cardiovascular Disease
- Child & Adolescent Psychiatry
- Critical Care Medicine
- Endocrinology, Diabetes & Metabolism
- Gastroenterology
- General Internal Medicine
- General Pediatrics
- Hospital Medicine
- Infectious Disease
- Medical Toxicology
- Metabolic & Bariatric Surgery
- Nephrology
- Neurology
- Obstetrics & Gynecology
- Pediatric Infectious Diseases
- Rheumatology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Pediatrics
- Primary care
- Psychiatry
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Live
- Credit · Up to 1 credit
-
WhenApr 22, 2026 – Apr 22, 2027
-
American College of Clinical Pharmacology ACCP Virtual Journal Club April 2026 – Assessment of Hepatic Impairment and Implications for Pharmacokinetics of Substance Use Treatment
-
American College of Clinical Pharmacology ACCP Virtual Journal Club October 2025 – Examining the Impact of Diet-and-Exercise-Induced Weight Loss on Drug Metabolism and Gastric Emptying in Patients with Obesity – On Demand
-
American College of Clinical Pharmacology ACCP Journal CE July 2025 – Pharmacokinetics and Safety of Fenofibrate in Participants with Mild Hepatic Impairment or with Advanced Fibrosis due to Metabolic-Associated Fatty Liver Disease
-
American Academy of Addiction Psychiatry PCSS-MOUD SUD 101 Course 6: Lab Testing in Assessment of Substance Use Disorders (2026)
-
American Society of Addiction Medicine Reductions in World Health Organization Risk Drinking Level are Associated with Reductions in Alcohol Use Disorder Diagnosis and Criteria Evidence from an Alcohol Pharmacotherapy Trial
-
Premiere Education +1 Unlocking Effective Treatments Pharmacology for Substance Use Disorder
